Mandragora comp. Soluzione iniettabile (s. c.)

Country: Շվեյցարիա

language: իտալերեն

source: Swissmedic (Swiss Agency for Therapeutic Products)

buyitnow

PIL PIL (PIL)
09-05-2024
SPC SPC (SPC)
09-05-2024

active_ingredient:

arnica montana ex planta tota Rh (HAB) D15, betula pendula e foliis Rh D3 (Ph.Eur.Hom. 1.5.2), equisetum arvense Rh D15, formica rufa ex animale toto D10 (Ph.Eur.Hom. 2.1.1), mandragora, ethanol. decoctum (HAB) D3, bos taurus e minisco genus vituli D6 (Ph.Eur.Hom. 2.1.1)

MAH:

Weleda AG

INN:

arnica montana ex planta tota Rh (HAB) D15, betula pendula e foliis Rh D3 (Ph.Eur.Hom. 1.5.2), equisetum arvense Rh D15, formica rufa ex animale toto D10 (Ph.Eur.Hom. 2.1.1), mandragora, ethanol. decoctum (HAB) D3, bos taurus e minisco genus vituli D6 (Ph.Eur.Hom. 2.1.1)

pharmaceutical_form:

Soluzione iniettabile (s. c.)

composition:

arnica montana ex planta tota Rh (HAB) D15 167 mg, betula pendula e foliis Rh D3 (Ph.Eur.Hom. 1.5.2) 167 mg, equisetum arvense Rh D15 167 mg, formica rufa ex animale toto D10 (Ph.Eur.Hom. 2.1.1) 167 mg, mandragora, ethanol. decoctum (HAB) D3 167 mg, bos taurus e minisco genus vituli D6 (Ph.Eur.Hom. 2.1.1) 167 mg, natrii chloridum corresp. natrium 4 mg, aqua ad iniectabile, ethanolum 96 per centum 1 mg, pro vitro 1 ml, corresp. ethanolum 0,7 % m/V.

class:

B

therapeutic_group:

Antroposofici

therapeutic_area:

Zulassung mit reduziertem Dossier ohne Indikation nach Art. 25 Abs. 1 KPAV (SR 812.212.24)

authorization_status:

zugelassen

authorization_date:

2013-08-28

documents_in_other_languages

PIL PIL ֆրանսերեն 09-05-2024
SPC SPC ֆրանսերեն 09-05-2024